BioSpace News Archive

Tolero Pharmaceuticals a clinical-stage company focused on developing novel therapeutics for hematological and oncological diseases, today announced that the first patient has been enrolled in a Phase 1b/2 study, Zella 102, evaluating the investigational agent alvocidib, a cyclin-dependent kinase 9 (CDK9) inhibitor, plus decitabine in patients with myelodysplastic syndromes (MDS).

Semler Scientific, Inc. (OTCQB: SMLR), an emerging growth company that provides technology and software solutions to improve the clinical effectiveness and efficiency of healthcare providers, today announced that it will report financial results for third quarter and nine months ended September 30, 2018

Quotient Sciences announces a significant expansion to its operations in the U.S. with the opening of a state-of-the-art, 45,000-square-foot facility located near Philadelphia, in Garnet Valley, Pa.

The Green Organic Dutchman Holdings Ltd. is pleased to announce it has received its medical sales license from Health Canada pursuant to the Access to Cannabis for Medical Purposes Regulations for its Ancaster, Ontario facility.

Global Healthcare Exchange, LLC (GHX), a healthcare business and data automation company, has added two senior executives to support and amplify the company’s growth plans.

A prospective study in patients with advanced non-small cell lung cancer (NSCLC) has demonstrated that the blood based Guardant360® assay, developed by Guardant Health

Florida Autism Center (FAC) is proud to announce the official opening of their 30th ABA therapy facility in Atlantic Beach.

Timberline Knolls Residential Treatment Center and SunCloud Health are hosting a free, one night only screening of the compelling documentary, All of Me, 5:30 – 8:30 p.m., Tuesday, November 13, 2018 at the Damen Cinema, Damen Student Center at Loyola University, 6511 N. Sheridan Road, Chicago.

The U.S. Department of Commerce’s Minority Business Development Agency (MBDA) proudly announces the professional achievements of 12 leaders of minority business enterprises (MBEs).

CVS Health (NYSE: CVS) announced today that it is embarking on a pilot project in the Tri-Cities area of Atlanta, Georgia, aimed at addressing diabetes in medically underserved communities with chronically high rates of this disease.